Skip to content

GRCE - Grace Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchG

Grace Therapeutics, Inc.

GRCE · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

G

GRCEGrace Therapeutics, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $5.18
52-wk low: $1.79
Prev close: $3.38
Mkt cap: $46.3M
Fwd P/E: 2.2x
Beta: 0.43

Smart money

6 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

6 holders

Combined position$3.8M

JS
Jim Simons
Q1 2026 13F
$1.1M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 2.17
Market cap: $46M

Valuation

P/S197.75
P/B0.93

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: GRCE
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $46.28M
Beta: 0.43

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

197.8x

P/B

0.9x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-36.2%

$794K

position

MW

Marshall Wace

Q1 2026 13F

$423K

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for GRCE

No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-36.2%

ROA-10.8%

Growth

Beta0.43